Shock - DIC and PIH - (1)

Disseminated Intravascular Coagulation (DIC)

Overview

  • Definition: DIC is characterized by widespread intravascular clotting and bleeding.

  • Causes: It is commonly initiated by endothelial damage or the release of tissue factor.

  • Pathophysiology:

    • Excess thrombin is generated, leading to widespread clotting.

    • Results in ischemia, infarction, and necrosis of tissues.

    • Overwhelms clotting factors, continuing the cycle of bleeding.

  • Common Situations: Frequently occurs alongside severe sepsis and septic shock.

Pathophysiology of DIC

  • Injury Response:

    • Endothelial damage and tissue factor release activate the intrinsic and extrinsic pathways of coagulation.

    • Massive thrombin release prompts intravascular coagulation.

  • Consequences:

    • Leads to vascular occlusion and tissue ischemia.

    • Increased consumption of clotting factors and activation of the fibrinolytic pathway causes diffuse bleeding.

Manifestations

  • Complications:

    • Initial inflammatory response prompts clotting, followed by fibrinolysis.

    • Depletion of platelets occurs due to their consumption in clot formation.

  • Bleeding: Development of bleeding as a significant manifestation of DIC.

Laboratory Findings in DIC

  • Platelet Count: Decreased.

  • Fibrinogen Level: Decreased.

  • PTT: Increased sensitivity.

  • PT: Increased sensitivity.

  • D-Dimer: Elevated levels.

  • Fibrin Split Products (FSP): Elevated.

Management of DIC

  • Focus: Must concentrate on identifying and treating the underlying cause.

    • If infection is present, administer antibiotics.

  • Bleeding Management:

    • Fresh Frozen Plasma (FFP) and platelets are given to replenish clotting factors.

    • Low-dose heparin may be utilized to balance for pathway deficiencies.

Nursing Considerations

  • Continuous assessment of all body systems is essential due to the widespread impact of DIC.

  • Implement bleeding precautions during patient care.

  • Lab Monitoring: Regular checks on BUN, creatinine, arterial blood gases (ABG), urine analysis, and hemoccult tests.

Pregnancy-Related Hypertension

Chronic Hypertension

  • Description: Present before pregnancy or diagnosed before 20 weeks gestation.

  • Continuation: Persists beyond 42 days postpartum.

  • Criteria: Systolic BP > 140 mmHg and diastolic BP > 90 mmHg.

Gestational Hypertension

  • Description: Onset occurs after 20 weeks gestation, resolving within 12 weeks postpartum.

  • Features: SBP > 140 mmHg and DBP > 90 mmHg without proteinuria.

  • Diagnosis: Conducted retrospectively if transient.

Preeclampsia

  • Definition: A significant condition during pregnancy indicating maternal vasospasm and possible hypoperfusion to the fetus.

  • Symptoms: May include headache, visual disturbances, and hyperreflexia.

  • Connection to DIC: Associated vascular endothelial damage can lead to DIC.

Comparison Chart: Preeclampsia vs. Eclampsia

  • Mild Preeclampsia: BP > 140/90 mmHg, proteinuria 300 mg/24 hr.

  • Severe Preeclampsia: BP > 160/110 mmHg, proteinuria > 500 mg/24 hr.

  • Eclampsia: Causes seizures, with marked proteinuria.

Medical Management

  • Antepartum: Emphasizes bed rest, frequent BP checks, daily weight, and urine protein monitoring.

  • Intrapartum: Requires continuous fetal monitoring.

  • Postpartum: Patients generally improve rapidly after delivery, though seizures can still occur for up to 48 hours post-delivery.

Fetal-Neonatal Risks

  • Effects: Increased risk for small gestational age (SGA), sedation at birth.

  • Hypermagnesemia: Related to maternal magnesium sulfate treatment.

Clinical Management for Pregnancy-Related Hypertension

  • Strategies:

    • Promote bed rest, monitor vital signs, and restrict sodium intake.

    • Administer magnesium sulfate, frequent BP monitoring required.

  • Immediate Care: Emergent delivery may be necessary if fetal distress is present.

HELLP Syndrome

  • Definition: Stands for hemolysis, elevated liver enzymes, and low platelets.

  • Association: Recognized as a complication in conditions like preeclampsia and eclampsia, often presenting in the third trimester.

  • Symptoms: Severe right upper quadrant pain, nausea, and liver distention related to DIC.

Medications for Hypertension

  • Common Medications: Include Magnesium Sulfate, Calcium Gluconate, Hydralazine, Labetalol, and Nifedipine.

  • Dosing: Must follow specific protocols to ensure safety and effectiveness.

Nursing Assessment for Hypertension in Pregnancy

  • Watch for:

    • Headaches, visual changes, decreased urine output, and weight gain.

    • Elevate BP readings indicating potential complications.

Eclampsia Overview

  • Definition: Characterized by seizures or coma during pregnancy in patients showing signs of preeclampsia.

  • Monitoring Needs: Keen observation for fetal hypoxia and possible complications such as cerebral hemorrhage.

robot